Scientist for Content Marketing (RenSuper Biologics)
Biocytogen
Summary
The Scientist for Content Marketing is responsible for collaborating with internal teams and developing marketing content in a variety of forms. He/she should be familiar with writing for the web, email marketing, and blog strategy and execution. He/she will produce high-quality content to increase brand awareness, execute marketing campaigns, drive engagement, and support inbound lead generation. He/she will also contribute to offline marketing initiatives, especially event/tradeshow planning.
Job description
Job Responsibilities:
Scientific content generation (50-75% effort)
- Write, edit, and generate informative and engaging content, including emails, brochures, e-newsletters, abstracts, case studies, website pages, infographics, slide decks, blog posts, and video scripts
- Maintain a content calendar to support various marketing campaigns and initiatives
- Use e-mail marketing software to design, execute, and track high-impact campaigns
- Engage with our sales team, internal service leaders and subject matter experts, and customers to understand client needs, uncover gaps in our existing assets, and identify relevant topics for new content
- Manage content projects from start to finish — from topic selection to content development to quality reviews of the final product to promotional messaging
- Update website content and recommend and implement site improvements
- Work with outside vendors, agencies, and consultants as necessary
Conference planning/preparation (25-50% effort)
- Assist with other general marketing program management support as needed, especially event registration, coordination, and preparing scientific congress presentations
Requirements
- Ph.D. in a relevant scientific discipline such as immunology, bioengineering, molecular biology, or a related field
- Familiarity with immunology, protein/antibody engineering, biochemistry, therapeutic antibody development, preclinical pharmacology, gene-targeting technologies, and the use of animal models
- 2-3 years of content creation or content marketing, ideally B2B preferred
- Experience writing, editing, and creating various types of long- and short-form content, such as whitepapers, case studies, blog posts, emails, website pages, and landing pages
- Excellent written, verbal, analytical, research, and communication skills
- Team player that must be willing to work closely and productively within a small team
- Self-motivated with the ability to manage multiple ongoing projects and meet deadlines
- Meticulous attention to detail
- Interest in building a deep understanding of our technical platforms, and the ability to translate that knowledge into relevant and valuable content
- Mandarin and English bilingual required
Benefits
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Health Reimbursement Accounts
- Life and AD&D Insurance
- Short-Term Disability Insurance
- Long-Term Disability Insurance
- 401(k) with Company Match
- Paid Time Off
- Paid Sick Days
- Paid Holidays
Company overview
Biocytogen is a global biotechnology company founded in 2009 that specializes in integrated solutions for next-generation antibody drug development. The company leverages cutting-edge gene editing technologies and proprietary RenMice® platforms (RenMab™, RenLite®, RenNano®, RenTCR-mimic™) to enable fully human monoclonal, bispecific, multispecific antibody, nanobody, and TCR-mimic antibody discovery. With a state-of-the-art animal facility and comprehensive preclinical validation capabilities, Biocytogen provides seamless integration from animal model generation to therapeutic antibody discovery and in vivo/in vitro preclinical studies. The company collaborates with more than 70% of the top 50 pharmaceutical and biotechnology companies worldwide and has established over 280 global discovery partnerships. Biocytogen operates through two main business divisions: BioMice™ for preclinical models and services, and RenBiologics™ for antibody drug R&D and out-licensing. Headquartered in Beijing with international operations in the US, Germany, and China, Biocytogen is publicly listed on both the Hong Kong Stock Exchange and Shanghai Stock Exchange STAR Market.